Shaw Brian Gordon 4/A

What Happened
Brian G. Shaw, a director of Ovintiv Inc., received 19,742 Ovintiv shares on February 3, 2026. The shares were recorded at $38.27 each, totaling $755,526. This was an issuance in connection with the NuVista plan of arrangement (an acquisition-related transaction), not an open-market purchase.

Key Details

• Transaction date and price: 2026-02-03; 19,742 shares at $38.27 per share (total reported $755,526).
• Filing: This is an amended Form 4. The original Form 4 (filed Feb 5, 2026) mistakenly reported 34,160 shares; final verification corrected the amount to 19,742 and holdings were updated accordingly.
• Transaction code: "J" (other acquisition/disposition) — reflects issuance under the NuVista arrangement rather than a standard purchase or sale.
• Shares owned after transaction: Updated in the amended filing to reflect the corrected receipt; the filing replaces the previously reported holdings.
• Timeliness: The filing was amended to correct the earlier report; the amendment does not itself indicate trading intent.

Context
This was a corporate transaction tied to the NuVista plan of arrangement — essentially share consideration from a business combination — and not a voluntary market buy that would signal a director buying stock on the open market. Amendments like this typically correct reporting details and do not, by themselves, imply a change in insider sentiment.